The global allergy diagnostics and therapeutics market size is expected to reach USD 9.93 billion by 2028 according to a new study by Polaris Market Research. The report “Allergy Diagnostics and Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Test (In vitro, In vivo); By Product; By Drug Class; By End-Use; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising population, increasing incidences of allergies, and growing healthcare expenditure drives the growth of the industry. Poor nutrition and environmental pollution have led to greater cases of allergies. The growing adoption of in vitro diagnostic tests and improvement in medical insurance policies has further supported the industry growth.
The industry has been impacted by the outbreak of COVID-19 due to lockdown, restriction on movement, reduced workforce, and operational challenges across the globe. There has been increasing adoption of telehealth solutions and virtual care to address delayed patient care during the pandemic.
Get sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-allergy-diagnostics-market/request-for-sample
On the basis of the test, the industry is segmented into in vitro and in vivo. The in vivo tests dominated the global industry in 2020. These tests provide reliable and valid diagnostic solutions by performing skin tests. The skin tests include exposure to standardized allergenic extracts through pricking and patch testing. These tests are quick, widely available, easy to use, and highly effective.
The allergy drug class segment has been divided into antihistamines, corticosteroids, leukotriene inhibitors, nasal anticholinergics, decongestants, and others. The antihistamines segment holds the largest market share in 2020. Antihistamines are prescribed for treating symptoms associated with allergies.
North America holds the largest revenue share in the global market for allergy diagnostics and therapeutics in 2020 and is expected to maintain its dominance over the forecast period. Increasing cases of respiratory illness and the growing adoption of in vitro tests support the market growth in this region.
Industry players are collaborating with each other for research & development, strengthening industry presence, and technological innovation. The greater need to cater to growing customer requirements has encouraged industry participants to leverage new technologies to develop high-quality products.
Complete Summary with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/global-allergy-diagnostics-market/toc
Polaris Market Research has segmented the allergy diagnostics and therapeutics market report on the basis of test, product, drug class, end-use, and region:
Allergy Diagnostics and Therapeutics, Test Outlook (Revenue, USD Billion, 2016 – 2028)
- In vitro
- In vivo
Allergy Diagnostics and Therapeutics, Product Outlook (Revenue, USD Billion, 2016 – 2028)
- Consumables
- Instruments
- Services
Allergy Diagnostics and Therapeutics, Drug Class Outlook (Revenue, USD Billion, 2016 – 2028)
- Corticosteroids
- Antihistamines
- Leukotriene Inhibitors
- Decongestants
- Nasal Anticholinergics
- Others
Allergy Diagnostics and Therapeutics, End-Use Outlook (Revenue, USD Billion, 2016 – 2028)
- Hospitals
- Diagnostics Labs
- Research & Development Centers
- Others
Allergy Diagnostics and Therapeutics, Regional Outlook (Revenue, USD Billion, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Netherlands
- Austria
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- South Africa
- Israel
- UAE
Avail discount on this report @ https://www.polarismarketresearch.com/industry-analysis/global-allergy-diagnostics-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
The global allergy diagnostics and therapeutics market size is expected to reach USD 9.93 billion by 2028 according to a new study by Polaris Market Research.
The report “Allergy Diagnostics and Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Test (In vitro, In vivo); By Product; By Drug Class; By End-Use; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The industry has been impacted by the outbreak of COVID-19 due to lockdown, restriction on movement, reduced workforce, and operational challenges across the globe.
There has been increasing adoption of telehealth solutions and virtual care to address delayed patient care during the pandemic.
Get sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-allergy-diagnostics-market/request-for-sample On the basis of the test, the industry is segmented into in vitro and in vivo.
These tests provide reliable and valid diagnostic solutions by performing skin tests.
Idiopathic Pulmonary Fibrosis (IPF) Treatment Market HighlightsIt is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2019 to 2025, with a market value of USD 2,237 million in 2018.IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period.
The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases.
However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market.The global IPF treatment market is currently dominated by numerous market players.
For instance, in September 2018, FibroGen, Inc. announced that the grant of Fast Track designation by US Food and Drug Administration (FDA) for the company’s anti-CTGF antibody, Pamrevlumab, for the treatment of patients with IPF.Idiopathic Pulmonary Fibrosis (IPF) Treatment Market SegmentationThe global IPF treatment market has been segmented based on treatment.The market, based on treatment, has been further divided into drug class, oxygen therapy, lung transplant, and others.
The drug class segment is likely to hold a major share in the market due to the increasing adoption of the drugs for the treatment of IPF and wider preferability.
The oxygen therapy segment is predicted to be the fastest growing due to the increasing inclination of medical professionals towards this therapy for the treatment of IPF.Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Key PlayersSome of the key players in the global IPF treatment market are Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibrogen, Inc., Cipla, Merck & Co., Inc., Prometic Life Sciences Inc., and others.Browse Full Report Details @ https://www.marketresearchfuture.com/reports/idiopathic-pulmonary-fibrosis-treatment-market-8109Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The global fitness equipment market size is expected to value at USD 13.24 billion by 2022.
The market is subject to witness a substantial growth due to the ever-growing urban population, increasing disposable income, particularly in the developing economies across the globe, and rising health consciousness among the general population.
Globally, the market is predicted to grow at CAGR of 3.6% in forecast period, providing numerous opportunities for market players to invest in research and development of the fitness equipment market.Download Full Research Report on “Fitness Equipment Market” @ https://www.millioninsights.com/industry-reports/fitness-equipment-marketThe fitness equipment that are increasingly used include treadmills, standing bicycles, abs & fitness twister, roller slide, cross trainer, and weightlifting machines.
Factors responsible for robust market growth in the fitness equipment industry, in the recent years, include large number of obese population, rising health consciousness among general population, and increasing popularity of fitness equipment among younger population.
Numerous initiatives undertaken by private and government authorities to promote corporate wellness programs are predicted to drive the growth of fitness equipment market in the upcoming years.
Furthermore, increasing popularity of the fitness equipment in the developed economies is attributed to factors such as rising healthcare expenditure, and development of sports and nutrition programs and initiatives in order to encourage people belong to all ages, and backgrounds, thereby leading to active and healthy lifestyle.This market is broadly categorized into three major types based on type of the device such as cardiovascular training, strength training, and body monitoring and analyzers.
The growth sectors of the Wearable Computing Market Share are identified with precision for a better growth perspective.The global wearable computing market was analyzed by Market Research Future (MRFR) and it was projected that a striking CAGR of 15% will be attained by the market over the forecast period of 2017 to 2023.
The valuation of the wearable computing market was further stated to surpass its previous figure to reach an estimated valuation of USD 35 Billion by 2023.The global market is experiencing a surging growth due to the increasing adoption of wristbands and smart watches among consumers.
Add to this, there is a burgeoning interest for networking, communication and recognition technologies for wearable products, thereby driving the global wearable computing market.
However, the high consumption rate of power and limited use of battery life can pose to be a challenge to the potential growth of the market over the forecast period.Market SegmentationThe global wearable computing market has been segmented in terms of product, end-user, and technology.By technology, the market segments into networking technologies, display technologies, and other technologies.
The networking technologies is narrowed down into Wi-Fi and Bluetooth, while the display technologies is broken down into augmented reality and virtual realityBy product, the market comprises activity monitoring device, smart clothing and textiles, wearable camera and virtual reality eyewear.By end-user, the market includes fitness & wellness, defense & security, medical & healthcare, infotainment, gaming, automation, home enterprise & industrial, and other applications.Healthcare & medical and fitness & wellness are expected to have a significant growth over the next few years.
The region currently leads the global market and is expected to remain the same in the coming years.
Market synopsis:The telematics market is majorly driven by certain factors such as increasing demand of wireless connectivity in automobiles, rising implementation of renewable sources of energy in electric vehicles, increasing information and communication technology and telecommunication in various industrial sectors, and initiatives by the government for on-road public safety.
AXIO-NET is a provider of global navigation satellite systems in countries like Germany, U.K. Samsung had announced telematics control unit (TCU) in collaboration with Harman technologies.
Zurich Insurance Group acquired Bright Box HK Ltd.
Many big enterprises like Harman, Samsung, LG, and AT are investing in research and development of innovative telematics solutions.
The driving factor of emerging digital technology has made possible the communication with machines and is further enhancing its growth in coming years.
(U.K.), Ford Motor Company (U.S.), BMW Group (Germany), Telefonica SA (Spain), Mix Telematics (South Africa), and Trimble Navigation Ltd. (U.S.) among others.Other vendors include Tantalum Corporation (U.K), InfoTrack Telematics (Japan), Agero Inc. (U.S.), NXP Semiconductors (the Netherlands), Smart Telematics Ltd, BOX telematics limited (U.K), AutoVision Wireless Inc (Canada), Ingenie (U.K), Calamp Corp. (U.S.), Vista Equity Partners (U.S.), ClickSoftware Technologies Ltd. (U.S.), ORBCOMM Inc. (U.S.) among others.The prominent players constantly keep innovating and investing in research and development in order to present a cost-effective portfolio.
